Publication

Reid DJ, Keener JE, Wheeler AP, Zambrano DE, Diesing JM, Reinhardt-Szyba M, Makarov A, Marty MT. 2017. Engineering Nanodisc Scaffold Proteins for Native Mass Spectrometry. Anal Chem. 89:11189–11192. doi:10.1021/acs.analchem.7b03569.

Aryanpur PP, Regan CA, Collins JM, Mittelmeier TM, Renner DM, Vergara AM, Brown NP, Bolger TA. 2017. Gle1 Regulates RNA Binding of the DEAD-Box Helicase Ded1 in Its Complex Role in Translation Initiation. Mol Cell Biol. 37. doi:10.1128/MCB.00139-17.

Carrington JM, Pace TWW, Sheppard KG, Dudding KM, Stratton D. 2017. Using Twitter to Teach Evidence-Based Practice in Doctor of Nursing Practice Degree Program. Clin Nurse Spec. 31:349–352. doi:10.1097/NUR.0000000000000336.

Tseng H-W, Fan J, Kupinski MA. 2017. Assessing computed tomography image quality for combined detection and estimation tasks. J Med Imaging (Bellingham). 4:045503. doi:10.1117/1.JMI.4.4.045503.

Farland LV, Lorrain S, Missmer SA, Dartois L, Cervenka I, Savoye I, Mesrine S, Boutron-Ruault M-C, Kvaskoff M. 2017. Endometriosis and the risk of skin cancer: a prospective cohort study. Cancer Causes Control. 28:1011–1019. doi:10.1007/s10552-017-0939-2.

Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al. 2017. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 171:273–285. doi:10.1016/j.cell.2017.09.021.

Carew JS, Espitia CM, Zhao W, Mita MM, Mita AC, Nawrocki ST. 2017. Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas. Oncotarget. 8:86769–86783. doi:10.18632/oncotarget.21423.

Chilton FH, Dutta R, Reynolds LM, Sergeant S, Mathias RA, Seeds MC. 2017. Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases. Nutrients. 9. doi:10.3390/nu9111165.

Snyder Valier AR, Welch Bacon CE, Bay RC, Molzen E, Lam KC, Valovich McLeod TC. 2017. Reference Values for the Pediatric Quality of Life Inventory and the Multidimensional Fatigue Scale in Adolescent Athletes by Sport and Sex. Am J Sports Med. 45:2723–2729. doi:10.1177/0363546517714471.

Goyal U, Prabhakar NK, Davuluri R, Morrison CM, Yi SK. 2017. Role of Concurrent Systemic Therapy with Adjuvant Radiation Therapy for Locally Advanced Cutaneous Head and Neck Squamous Cell Carcinoma. Cureus. 9:e1784. doi:10.7759/cureus.1784.

Galick HA, Marsden CG, Kathe S, Dragon JA, Volk L, Nemec AA, Wallace SS, Prakash A, Doublié S, Sweasy JB. 2017. The NEIL1 G83D germline DNA glycosylase variant induces genomic instability and cellular transformation. Oncotarget. 8:85883–85895. doi:10.18632/oncotarget.20716.

Kwon JS, Everetts NJ, Wang X, Wang W, Della Croce K, Xing J, Yao G. 2017. Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch. Cell Rep. 20:3223–3235. doi:10.1016/j.celrep.2017.09.007.

Daniel SG, Ball CL, Besselsen DG, Doetschman T, Hurwitz BL. 2017. Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor β-Deficient Colon Cancer. mSystems. 2. doi:10.1128/mSystems.00065-17.

Majuta LA, Guedon J-MG, Mitchell SAT, Kuskowski MA, Mantyh PW. 2017. Mice with cancer-induced bone pain show a marked decline in day/night activity. Pain Rep. 2:e614. doi:10.1097/PR9.0000000000000614.

Ghanbari N, Clarkson E, Kupinski M, Li X. 2017. Optimization of an Adaptive SPECT System with the Scanning Linear Estimator. IEEE Trans Radiat Plasma Med Sci. 1:435–443. doi:10.1109/TRPMS.2017.2715041.

Thomson CA, Sherry Chow HH, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, et al. 2017. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 165:97–107. doi:10.1007/s10549-017-4292-7.

Yu L, Chen B, Kofler JM, Favazza CP, Leng S, Kupinski MA, McCollough CH. 2017. Correlation between a 2D channelized Hotelling observer and human observers in a low-contrast detection task with multislice reading in CT. Med Phys. 44:3990–3999. doi:10.1002/mp.12380.

Gasperini M, Findlay GM, McKenna A, Milbank JH, Lee C, Zhang MD, Cusanovich DA, Shendure J. 2017. CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions. Am J Hum Genet. 101:192–205. doi:10.1016/j.ajhg.2017.06.010.

Bell ML, Fiero MH, Dhillon HM, Bray VJ, Vardy JL. 2017. Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes. Ann Oncol. 28:1730–1733. doi:10.1093/annonc/mdx064.

Geisler CE, Renquist BJ. 2017. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 234:R1-R21. doi:10.1530/JOE-16-0513.

Ozdilek BA, Thompson VF, Ahmed NS, White CI, Batey RT, Schwartz JC. 2017. Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 45:7984–7996. doi:10.1093/nar/gkx460.

Weiss GJ, Waypa J, Blaydorn L, Coats J, McGahey K, Sangal A, Niu J, Lynch CA, Farley JH, Khemka V. 2017. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus). Br J Cancer. 117:33–40. doi:10.1038/bjc.2017.145.

Smeester L, Bommarito PA, Martin EM, Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, Lantz RC, Fry RC. 2017. Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response. Environmental Toxicology and Pharmacology. 52:183–187. doi:10.1016/j.etap.2017.04.007.

Smeester L, Bommarito PA, Martin EM, Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, Clark Lantz R, Fry RC. 2017. Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response. Environ Toxicol Pharmacol. 52:183–187. doi:10.1016/j.etap.2017.04.007.

Carew JS, Espitia CM, Zhao W, Han Y, Visconte V, Phillips J, Nawrocki ST. 2017. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clin Cancer Res. 23:2869–2879. doi:10.1158/1078-0432.CCR-16-1742.